Here are the top headlines from Fox Business Flash. Check out what is clicking on FoxBusiness.com.
Britain has received two million doses of Modern Inc.’s COVID-19 vaccine candidate, which is due to be available in Europe in early spring, the government said on Sunday. In addition to the 5 million doses received from the company.
The new deal comes a day after Prime Minister Boris Johnson was appointed junior trade minister Nadhim Zahawi responsible for organizing the Covid-19 vaccines.
Get Fox Business on the go by clicking here
Britain now has adequate dose access to the modern vaccine candidate for about 3.5 million people. In total, it has access to 357 million doses of the vaccine from seven developers, the government statement said.
“With a wide range of vaccine candidates in our portfolio, we are ready to put the vaccine, they should get the approval of the drug regulator, starting with who will benefit the most,” Health Minister Matt Hancock said in a statement.
Modern for Covid-19 vaccine $ 25-CH 37: CEO tells the paper
Modern experimental vaccines are 94.5% effective in preventing COVID-19 based on interim data from late-stage trials.
If the vaccine meets the standards of the Medicines and Healthcare Products Regulatory Agency, delivery to the UK could begin as early as spring.
Britain has also ordered 40 million doses of the vaccine, developed by Germany’s Bioentech SE and Pfizer Inc. of the United States, which have been found to be 95% effective in preventing the spread of the new coronavirus.
| Ticker | Security | The last | Change | Change% |
|---|---|---|---|---|
| MRNA | Modern INC. | 127.03 | +17.85 | + 16.35% |
The UK regulator is set to approve the Bioentech-Pfizer vaccine this week, and delivery will begin within hours of being authorized, the Financial Times reported on Saturday.
Britain has also secured 100 million doses of the vaccine developed by AstraZeneca PLC and Oxford University and is targeting a rollout starting before Christmas.
Click here to read more on Fox Business
(Reporting by Radhika Anilkumar in Bengaluru; Additional reporting by Maria Ponezath in Bengaluru; Editing by Himani Sarkar and William Mallard)
